Company intelligence / Profile preview

Allde Medi Impex

New Delhi, Delhi, India

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Alde Medi Impex is an established Indian pharmaceutical company with over 300 registered products, a broad therapeutic portfolio, and both domestic and emerging international presence. The company is WHO and GMP certified, with a focus on quality and innovation. It has undergone significant growth between 2014–2019 and plans further expansion with increased EBITDA margins. However, there is no evidence in the search results of proprietary clinical-stage drug candidates or novel platform technologies; the company appears to focus on commercializing established pharmaceutical and nutraceutical products.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Biotech

Partnerships

Max HospitalsApollo HospitalsSir Ganga Ram Hospital

Beyond the preview

Go deeper on Allde Medi Impex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allde Medi Impex.

Explore the full profile